DalsnaFinance › Analyst accuracy › Morgan Stanley › MRNA target
Morgan Stanley raises Moderna stock price target to $89 on platform strength
Morgan Stanley raised its price target on Moderna Inc. shares to $89 from $39 while maintaining an Equalweight rating on the stock.
A fact about what Morgan Stanley published, as reported by Investing.com, not a recommendation from Dalsna Finance; Morgan Stanley is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.